The Trump administration is hinting at an upcoming rule aimed at implementing the President’s “most favored nation” drug pricing policy. The proposed policy is titled “global benchmark for efficient drug pricing (GLOBE) model” and no details were given beyond the
read moreIn an expansion of its previous moves to cut the price of insulin in the U.S., Sanofi now will cap the price for all of its insulin products at $35 per month regardless of a patient’s insurance status. More: Sanofi
read moreAstraZeneca is the latest Big Pharma to unveil a digital direct-to-consumer platform offering certain medicines at heavily reduced prices to cash-pay patients. More: AstraZeneca joins the DTC platform pack, offering up to 70% discounts on Farxiga, Airsupra Source: fierce
read moreAmgen has spent the last three decades building out its presence in Puerto Rico. With a $650 million investment revealed Friday, the company’s site in Juncos is set to grow again. More: Amgen lays out 0M to grow Puerto Rico
read moreThe 100% rate floated in Donald Trump’s new communique on pharmaceutical tariffs may appear steep, but the reality of the situation is likely less severe than it seems, multiple analysts wrote Friday following the president’s latest act of social media
read more© 1994 - 2025 B.M. Pharmaceuticals